Cabaletta Bio, Inc.
CABA
$1.21
$0.054.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 43.28% | 64.88% | 66.75% | 54.86% | 51.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 67.61% | 68.84% | 64.34% | 47.57% | 37.90% |
| Operating Income | -67.61% | -68.84% | -64.34% | -47.57% | -37.90% |
| Income Before Tax | -71.21% | -66.71% | -56.60% | -37.55% | -27.75% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -71.21% | -66.71% | -56.60% | -37.55% | -27.75% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -71.21% | -66.71% | -56.60% | -37.55% | -27.75% |
| EBIT | -67.61% | -68.84% | -64.34% | -47.57% | -37.90% |
| EBITDA | -68.54% | -70.15% | -65.82% | -48.46% | -38.28% |
| EPS Basic | -41.44% | -25.38% | -9.79% | 5.23% | 8.59% |
| Normalized Basic EPS | -41.46% | -25.39% | -9.79% | 5.24% | 8.60% |
| EPS Diluted | -41.47% | -25.43% | -9.82% | 5.50% | 8.80% |
| Normalized Diluted EPS | -41.46% | -25.39% | -9.79% | 5.24% | 8.60% |
| Average Basic Shares Outstanding | 20.95% | 30.16% | 40.58% | 43.85% | 40.00% |
| Average Diluted Shares Outstanding | 20.95% | 30.16% | 40.58% | 43.85% | 40.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |